nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefpodoxime—Ceftibuten—SLC15A2—melanoma	0.00597	0.123	CrCbGaD
Cefpodoxime—Cefepime—SLC15A2—melanoma	0.00491	0.101	CrCbGaD
Cefpodoxime—Cefuroxime—SLC15A2—melanoma	0.00445	0.0914	CrCbGaD
Cefpodoxime—Cefixime—SLC15A2—melanoma	0.00385	0.079	CrCbGaD
Cefpodoxime—Ceftazidime—SLC15A2—melanoma	0.00362	0.0742	CrCbGaD
Cefpodoxime—Cefdinir—SLC15A2—melanoma	0.00355	0.0729	CrCbGaD
Cefpodoxime—Cefaclor—SLC15A2—melanoma	0.00352	0.0722	CrCbGaD
Cefpodoxime—Cefradine—SLC15A2—melanoma	0.00337	0.0692	CrCbGaD
Cefpodoxime—Cefadroxil—SLC15A2—melanoma	0.00319	0.0655	CrCbGaD
Cefpodoxime—Pancytopenia—Temozolomide—melanoma	0.003	0.00315	CcSEcCtD
Cefpodoxime—Haemorrhage—Bleomycin—melanoma	0.003	0.00315	CcSEcCtD
Cefpodoxime—Dysuria—Temozolomide—melanoma	0.00295	0.0031	CcSEcCtD
Cefpodoxime—Neutropenia—Temozolomide—melanoma	0.00295	0.0031	CcSEcCtD
Cefpodoxime—Hyperglycaemia—Carmustine—melanoma	0.00295	0.0031	CcSEcCtD
Cefpodoxime—Pneumonia—Carmustine—melanoma	0.00293	0.00308	CcSEcCtD
Cefpodoxime—Pollakiuria—Temozolomide—melanoma	0.00292	0.00307	CcSEcCtD
Cefpodoxime—Agranulocytosis—Dactinomycin—melanoma	0.0029	0.00305	CcSEcCtD
Cefpodoxime—Photosensitivity reaction—Temozolomide—melanoma	0.00288	0.00303	CcSEcCtD
Cefpodoxime—Weight increased—Temozolomide—melanoma	0.00287	0.00302	CcSEcCtD
Cefpodoxime—Renal failure—Carmustine—melanoma	0.00286	0.00301	CcSEcCtD
Cefpodoxime—Hyperglycaemia—Temozolomide—melanoma	0.00285	0.00299	CcSEcCtD
Cefpodoxime—Stomatitis—Carmustine—melanoma	0.00284	0.00298	CcSEcCtD
Cefpodoxime—Pneumonia—Temozolomide—melanoma	0.00283	0.00298	CcSEcCtD
Cefpodoxime—Stevens-Johnson syndrome—Temozolomide—melanoma	0.00279	0.00293	CcSEcCtD
Cefpodoxime—Cefotaxime—SLC15A2—melanoma	0.00278	0.0571	CrCbGaD
Cefpodoxime—Body temperature increased—Vemurafenib—melanoma	0.00278	0.00292	CcSEcCtD
Cefpodoxime—Stomatitis—Temozolomide—melanoma	0.00274	0.00288	CcSEcCtD
Cefpodoxime—Ceftriaxone—SLC15A2—melanoma	0.00274	0.0563	CrCbGaD
Cefpodoxime—Chills—Bleomycin—melanoma	0.00269	0.00283	CcSEcCtD
Cefpodoxime—Cardiac failure congestive—Docetaxel—melanoma	0.00268	0.00282	CcSEcCtD
Cefpodoxime—Alopecia—Bleomycin—melanoma	0.00265	0.00278	CcSEcCtD
Cefpodoxime—Erythema multiforme—Dactinomycin—melanoma	0.00264	0.00278	CcSEcCtD
Cefpodoxime—Sinusitis—Temozolomide—melanoma	0.00264	0.00278	CcSEcCtD
Cefpodoxime—Haemoglobin—Carmustine—melanoma	0.00263	0.00276	CcSEcCtD
Cefpodoxime—Haemorrhage—Carmustine—melanoma	0.00261	0.00275	CcSEcCtD
Cefpodoxime—Hallucination—Carmustine—melanoma	0.0026	0.00273	CcSEcCtD
Cefpodoxime—Hypersensitivity—Vemurafenib—melanoma	0.00259	0.00272	CcSEcCtD
Cefpodoxime—Oedema peripheral—Carmustine—melanoma	0.00258	0.00271	CcSEcCtD
Cefpodoxime—Renal impairment—Docetaxel—melanoma	0.00255	0.00268	CcSEcCtD
Cefpodoxime—Dermatitis bullous—Docetaxel—melanoma	0.00254	0.00267	CcSEcCtD
Cefpodoxime—Haemoglobin—Temozolomide—melanoma	0.00254	0.00267	CcSEcCtD
Cefpodoxime—Haemorrhage—Temozolomide—melanoma	0.00253	0.00266	CcSEcCtD
Cefpodoxime—Asthenia—Vemurafenib—melanoma	0.00252	0.00265	CcSEcCtD
Cefpodoxime—Hallucination—Temozolomide—melanoma	0.00251	0.00264	CcSEcCtD
Cefpodoxime—Chills—Dactinomycin—melanoma	0.00251	0.00263	CcSEcCtD
Cefpodoxime—Oedema peripheral—Temozolomide—melanoma	0.00249	0.00262	CcSEcCtD
Cefpodoxime—Pruritus—Vemurafenib—melanoma	0.00248	0.00261	CcSEcCtD
Cefpodoxime—Alopecia—Dactinomycin—melanoma	0.00247	0.00259	CcSEcCtD
Cefpodoxime—Hyponatraemia—Docetaxel—melanoma	0.00244	0.00256	CcSEcCtD
Cefpodoxime—Ill-defined disorder—Bleomycin—melanoma	0.00242	0.00254	CcSEcCtD
Cefpodoxime—Anaemia—Bleomycin—melanoma	0.00241	0.00253	CcSEcCtD
Cefpodoxime—Diarrhoea—Vemurafenib—melanoma	0.0024	0.00253	CcSEcCtD
Cefpodoxime—Cefalotin—SLC15A2—melanoma	0.0024	0.0493	CrCbGaD
Cefpodoxime—Migraine—Docetaxel—melanoma	0.00239	0.00251	CcSEcCtD
Cefpodoxime—Erythema multiforme—Temozolomide—melanoma	0.00239	0.00251	CcSEcCtD
Cefpodoxime—Tinnitus—Temozolomide—melanoma	0.00236	0.00248	CcSEcCtD
Cefpodoxime—Malaise—Bleomycin—melanoma	0.00235	0.00247	CcSEcCtD
Cefpodoxime—Leukopenia—Bleomycin—melanoma	0.00233	0.00245	CcSEcCtD
Cefpodoxime—Dizziness—Vemurafenib—melanoma	0.00232	0.00244	CcSEcCtD
Cefpodoxime—Alopecia—Carmustine—melanoma	0.00231	0.00243	CcSEcCtD
Cefpodoxime—Cough—Bleomycin—melanoma	0.00228	0.00239	CcSEcCtD
Cefpodoxime—Chills—Temozolomide—melanoma	0.00227	0.00238	CcSEcCtD
Cefpodoxime—Dehydration—Docetaxel—melanoma	0.00226	0.00237	CcSEcCtD
Cefpodoxime—Ill-defined disorder—Dactinomycin—melanoma	0.00226	0.00237	CcSEcCtD
Cefpodoxime—Anaemia—Dactinomycin—melanoma	0.00225	0.00236	CcSEcCtD
Cefpodoxime—Vomiting—Vemurafenib—melanoma	0.00223	0.00235	CcSEcCtD
Cefpodoxime—Alopecia—Temozolomide—melanoma	0.00223	0.00235	CcSEcCtD
Cefpodoxime—Dry skin—Docetaxel—melanoma	0.00223	0.00234	CcSEcCtD
Cefpodoxime—Chest pain—Bleomycin—melanoma	0.00222	0.00233	CcSEcCtD
Cefpodoxime—Myalgia—Bleomycin—melanoma	0.00222	0.00233	CcSEcCtD
Cefpodoxime—Rash—Vemurafenib—melanoma	0.00221	0.00233	CcSEcCtD
Cefpodoxime—Dermatitis—Vemurafenib—melanoma	0.00221	0.00233	CcSEcCtD
Cefpodoxime—Back pain—Carmustine—melanoma	0.0022	0.00231	CcSEcCtD
Cefpodoxime—Headache—Vemurafenib—melanoma	0.0022	0.00231	CcSEcCtD
Cefpodoxime—Discomfort—Bleomycin—melanoma	0.00219	0.00231	CcSEcCtD
Cefpodoxime—Malaise—Dactinomycin—melanoma	0.00219	0.00231	CcSEcCtD
Cefpodoxime—Aspartate aminotransferase increased—Docetaxel—melanoma	0.00219	0.0023	CcSEcCtD
Cefpodoxime—Toxic epidermal necrolysis—Docetaxel—melanoma	0.00219	0.0023	CcSEcCtD
Cefpodoxime—Cephalexin—SLC15A2—melanoma	0.00218	0.0448	CrCbGaD
Cefpodoxime—Leukopenia—Dactinomycin—melanoma	0.00218	0.00229	CcSEcCtD
Cefpodoxime—Dysgeusia—Temozolomide—melanoma	0.00215	0.00226	CcSEcCtD
Cefpodoxime—Confusional state—Bleomycin—melanoma	0.00215	0.00226	CcSEcCtD
Cefpodoxime—Alanine aminotransferase increased—Docetaxel—melanoma	0.00214	0.00225	CcSEcCtD
Cefpodoxime—Tremor—Carmustine—melanoma	0.00213	0.00224	CcSEcCtD
Cefpodoxime—Anaphylactic shock—Bleomycin—melanoma	0.00213	0.00224	CcSEcCtD
Cefpodoxime—Back pain—Temozolomide—melanoma	0.00213	0.00224	CcSEcCtD
Cefpodoxime—Anaemia—Carmustine—melanoma	0.0021	0.00221	CcSEcCtD
Cefpodoxime—Agitation—Carmustine—melanoma	0.00209	0.0022	CcSEcCtD
Cefpodoxime—Nausea—Vemurafenib—melanoma	0.00209	0.00219	CcSEcCtD
Cefpodoxime—Thrombocytopenia—Bleomycin—melanoma	0.00208	0.00219	CcSEcCtD
Cefpodoxime—Myalgia—Dactinomycin—melanoma	0.00207	0.00218	CcSEcCtD
Cefpodoxime—Tremor—Temozolomide—melanoma	0.00206	0.00217	CcSEcCtD
Cefpodoxime—Discomfort—Dactinomycin—melanoma	0.00205	0.00215	CcSEcCtD
Cefpodoxime—Ill-defined disorder—Temozolomide—melanoma	0.00204	0.00215	CcSEcCtD
Cefpodoxime—Leukopenia—Carmustine—melanoma	0.00204	0.00214	CcSEcCtD
Cefpodoxime—Anaemia—Temozolomide—melanoma	0.00203	0.00214	CcSEcCtD
Cefpodoxime—Anorexia—Bleomycin—melanoma	0.00203	0.00213	CcSEcCtD
Cefpodoxime—Agitation—Temozolomide—melanoma	0.00202	0.00212	CcSEcCtD
Cefpodoxime—Pancytopenia—Docetaxel—melanoma	0.00199	0.0021	CcSEcCtD
Cefpodoxime—Hypotension—Bleomycin—melanoma	0.00199	0.00209	CcSEcCtD
Cefpodoxime—Malaise—Temozolomide—melanoma	0.00198	0.00208	CcSEcCtD
Cefpodoxime—Vertigo—Temozolomide—melanoma	0.00198	0.00208	CcSEcCtD
Cefpodoxime—Convulsion—Carmustine—melanoma	0.00197	0.00207	CcSEcCtD
Cefpodoxime—Leukopenia—Temozolomide—melanoma	0.00197	0.00207	CcSEcCtD
Cefpodoxime—Hypertension—Carmustine—melanoma	0.00196	0.00207	CcSEcCtD
Cefpodoxime—Neutropenia—Docetaxel—melanoma	0.00196	0.00206	CcSEcCtD
Cefpodoxime—Palpitations—Temozolomide—melanoma	0.00194	0.00204	CcSEcCtD
Cefpodoxime—Thrombocytopenia—Dactinomycin—melanoma	0.00194	0.00204	CcSEcCtD
Cefpodoxime—Musculoskeletal discomfort—Bleomycin—melanoma	0.00194	0.00204	CcSEcCtD
Cefpodoxime—Myalgia—Carmustine—melanoma	0.00194	0.00204	CcSEcCtD
Cefpodoxime—Chest pain—Carmustine—melanoma	0.00194	0.00204	CcSEcCtD
Cefpodoxime—Anxiety—Carmustine—melanoma	0.00193	0.00203	CcSEcCtD
Cefpodoxime—Cough—Temozolomide—melanoma	0.00192	0.00202	CcSEcCtD
Cefpodoxime—Paraesthesia—Bleomycin—melanoma	0.00191	0.00201	CcSEcCtD
Cefpodoxime—Weight increased—Docetaxel—melanoma	0.00191	0.00201	CcSEcCtD
Cefpodoxime—Convulsion—Temozolomide—melanoma	0.00191	0.002	CcSEcCtD
Cefpodoxime—Hypertension—Temozolomide—melanoma	0.0019	0.002	CcSEcCtD
Cefpodoxime—Dyspnoea—Bleomycin—melanoma	0.0019	0.00199	CcSEcCtD
Cefpodoxime—Anorexia—Dactinomycin—melanoma	0.00189	0.00199	CcSEcCtD
Cefpodoxime—Pneumonia—Docetaxel—melanoma	0.00188	0.00198	CcSEcCtD
Cefpodoxime—Confusional state—Carmustine—melanoma	0.00187	0.00197	CcSEcCtD
Cefpodoxime—Myalgia—Temozolomide—melanoma	0.00187	0.00197	CcSEcCtD
Cefpodoxime—Anxiety—Temozolomide—melanoma	0.00187	0.00196	CcSEcCtD
Cefpodoxime—Stevens-Johnson syndrome—Docetaxel—melanoma	0.00186	0.00195	CcSEcCtD
Cefpodoxime—Discomfort—Temozolomide—melanoma	0.00185	0.00194	CcSEcCtD
Cefpodoxime—Decreased appetite—Bleomycin—melanoma	0.00185	0.00194	CcSEcCtD
Cefpodoxime—Renal failure—Docetaxel—melanoma	0.00184	0.00193	CcSEcCtD
Cefpodoxime—Dry mouth—Temozolomide—melanoma	0.00183	0.00193	CcSEcCtD
Cefpodoxime—Stomatitis—Docetaxel—melanoma	0.00182	0.00192	CcSEcCtD
Cefpodoxime—Pain—Bleomycin—melanoma	0.00182	0.00191	CcSEcCtD
Cefpodoxime—Thrombocytopenia—Carmustine—melanoma	0.00182	0.00191	CcSEcCtD
Cefpodoxime—Confusional state—Temozolomide—melanoma	0.00181	0.0019	CcSEcCtD
Cefpodoxime—Musculoskeletal discomfort—Dactinomycin—melanoma	0.00181	0.0019	CcSEcCtD
Cefpodoxime—Anaphylactic shock—Temozolomide—melanoma	0.0018	0.00189	CcSEcCtD
Cefpodoxime—Anorexia—Carmustine—melanoma	0.00177	0.00186	CcSEcCtD
Cefpodoxime—Epistaxis—Docetaxel—melanoma	0.00177	0.00186	CcSEcCtD
Cefpodoxime—Thrombocytopenia—Temozolomide—melanoma	0.00176	0.00185	CcSEcCtD
Cefpodoxime—Feeling abnormal—Bleomycin—melanoma	0.00175	0.00184	CcSEcCtD
Cefpodoxime—Agranulocytosis—Docetaxel—melanoma	0.00175	0.00184	CcSEcCtD
Cefpodoxime—Hypotension—Carmustine—melanoma	0.00174	0.00182	CcSEcCtD
Cefpodoxime—Hyperhidrosis—Temozolomide—melanoma	0.00174	0.00182	CcSEcCtD
Cefpodoxime—Decreased appetite—Dactinomycin—melanoma	0.00173	0.00181	CcSEcCtD
Cefpodoxime—Fatigue—Dactinomycin—melanoma	0.00171	0.0018	CcSEcCtD
Cefpodoxime—Anorexia—Temozolomide—melanoma	0.00171	0.0018	CcSEcCtD
Cefpodoxime—Pain—Dactinomycin—melanoma	0.0017	0.00178	CcSEcCtD
Cefpodoxime—Musculoskeletal discomfort—Carmustine—melanoma	0.00169	0.00178	CcSEcCtD
Cefpodoxime—Urticaria—Bleomycin—melanoma	0.00169	0.00178	CcSEcCtD
Cefpodoxime—Haemoglobin—Docetaxel—melanoma	0.00169	0.00178	CcSEcCtD
Cefpodoxime—Rhinitis—Docetaxel—melanoma	0.00168	0.00177	CcSEcCtD
Cefpodoxime—Body temperature increased—Bleomycin—melanoma	0.00168	0.00177	CcSEcCtD
Cefpodoxime—Haemorrhage—Docetaxel—melanoma	0.00168	0.00177	CcSEcCtD
Cefpodoxime—Insomnia—Carmustine—melanoma	0.00168	0.00177	CcSEcCtD
Cefpodoxime—Paraesthesia—Carmustine—melanoma	0.00167	0.00175	CcSEcCtD
Cefpodoxime—Dyspnoea—Carmustine—melanoma	0.00166	0.00174	CcSEcCtD
Cefpodoxime—Oedema peripheral—Docetaxel—melanoma	0.00166	0.00174	CcSEcCtD
Cefpodoxime—Somnolence—Carmustine—melanoma	0.00165	0.00174	CcSEcCtD
Cefpodoxime—Feeling abnormal—Dactinomycin—melanoma	0.00164	0.00172	CcSEcCtD
Cefpodoxime—Musculoskeletal discomfort—Temozolomide—melanoma	0.00164	0.00172	CcSEcCtD
Cefpodoxime—Insomnia—Temozolomide—melanoma	0.00162	0.00171	CcSEcCtD
Cefpodoxime—Gastrointestinal pain—Dactinomycin—melanoma	0.00162	0.00171	CcSEcCtD
Cefpodoxime—Decreased appetite—Carmustine—melanoma	0.00161	0.0017	CcSEcCtD
Cefpodoxime—Paraesthesia—Temozolomide—melanoma	0.00161	0.00169	CcSEcCtD
Cefpodoxime—Gastrointestinal disorder—Carmustine—melanoma	0.0016	0.00169	CcSEcCtD
Cefpodoxime—Dyspnoea—Temozolomide—melanoma	0.0016	0.00168	CcSEcCtD
Cefpodoxime—Somnolence—Temozolomide—melanoma	0.0016	0.00168	CcSEcCtD
Cefpodoxime—Erythema multiforme—Docetaxel—melanoma	0.00159	0.00167	CcSEcCtD
Cefpodoxime—Pain—Carmustine—melanoma	0.00159	0.00167	CcSEcCtD
Cefpodoxime—Constipation—Carmustine—melanoma	0.00159	0.00167	CcSEcCtD
Cefpodoxime—Dyspepsia—Temozolomide—melanoma	0.00158	0.00166	CcSEcCtD
Cefpodoxime—Abdominal pain—Dactinomycin—melanoma	0.00157	0.00165	CcSEcCtD
Cefpodoxime—Body temperature increased—Dactinomycin—melanoma	0.00157	0.00165	CcSEcCtD
Cefpodoxime—Hypersensitivity—Bleomycin—melanoma	0.00157	0.00165	CcSEcCtD
Cefpodoxime—Decreased appetite—Temozolomide—melanoma	0.00156	0.00164	CcSEcCtD
Cefpodoxime—Gastrointestinal disorder—Temozolomide—melanoma	0.00155	0.00163	CcSEcCtD
Cefpodoxime—Fatigue—Temozolomide—melanoma	0.00155	0.00163	CcSEcCtD
Cefpodoxime—Constipation—Temozolomide—melanoma	0.00153	0.00161	CcSEcCtD
Cefpodoxime—Pain—Temozolomide—melanoma	0.00153	0.00161	CcSEcCtD
Cefpodoxime—Feeling abnormal—Carmustine—melanoma	0.00153	0.00161	CcSEcCtD
Cefpodoxime—Asthenia—Bleomycin—melanoma	0.00153	0.0016	CcSEcCtD
Cefpodoxime—Gastrointestinal pain—Carmustine—melanoma	0.00152	0.0016	CcSEcCtD
Cefpodoxime—Chills—Docetaxel—melanoma	0.00151	0.00158	CcSEcCtD
Cefpodoxime—Pruritus—Bleomycin—melanoma	0.00151	0.00158	CcSEcCtD
Cefpodoxime—Alopecia—Docetaxel—melanoma	0.00148	0.00156	CcSEcCtD
Cefpodoxime—Feeling abnormal—Temozolomide—melanoma	0.00148	0.00155	CcSEcCtD
Cefpodoxime—Abdominal pain—Carmustine—melanoma	0.00147	0.00154	CcSEcCtD
Cefpodoxime—Body temperature increased—Carmustine—melanoma	0.00147	0.00154	CcSEcCtD
Cefpodoxime—Gastrointestinal pain—Temozolomide—melanoma	0.00147	0.00154	CcSEcCtD
Cefpodoxime—Hypersensitivity—Dactinomycin—melanoma	0.00146	0.00154	CcSEcCtD
Cefpodoxime—Dysgeusia—Docetaxel—melanoma	0.00143	0.00151	CcSEcCtD
Cefpodoxime—Urticaria—Temozolomide—melanoma	0.00143	0.0015	CcSEcCtD
Cefpodoxime—Asthenia—Dactinomycin—melanoma	0.00142	0.0015	CcSEcCtD
Cefpodoxime—Body temperature increased—Temozolomide—melanoma	0.00142	0.00149	CcSEcCtD
Cefpodoxime—Abdominal pain—Temozolomide—melanoma	0.00142	0.00149	CcSEcCtD
Cefpodoxime—Back pain—Docetaxel—melanoma	0.00141	0.00149	CcSEcCtD
Cefpodoxime—Hypersensitivity—Carmustine—melanoma	0.00137	0.00144	CcSEcCtD
Cefpodoxime—Diarrhoea—Dactinomycin—melanoma	0.00136	0.00143	CcSEcCtD
Cefpodoxime—Vomiting—Bleomycin—melanoma	0.00135	0.00142	CcSEcCtD
Cefpodoxime—Anaemia—Docetaxel—melanoma	0.00135	0.00142	CcSEcCtD
Cefpodoxime—Rash—Bleomycin—melanoma	0.00134	0.00141	CcSEcCtD
Cefpodoxime—Dermatitis—Bleomycin—melanoma	0.00134	0.00141	CcSEcCtD
Cefpodoxime—Asthenia—Carmustine—melanoma	0.00133	0.0014	CcSEcCtD
Cefpodoxime—Hypersensitivity—Temozolomide—melanoma	0.00132	0.00139	CcSEcCtD
Cefpodoxime—Syncope—Docetaxel—melanoma	0.00131	0.00138	CcSEcCtD
Cefpodoxime—Leukopenia—Docetaxel—melanoma	0.00131	0.00138	CcSEcCtD
Cefpodoxime—Palpitations—Docetaxel—melanoma	0.00129	0.00136	CcSEcCtD
Cefpodoxime—Asthenia—Temozolomide—melanoma	0.00129	0.00135	CcSEcCtD
Cefpodoxime—Loss of consciousness—Docetaxel—melanoma	0.00129	0.00135	CcSEcCtD
Cefpodoxime—Cough—Docetaxel—melanoma	0.00128	0.00134	CcSEcCtD
Cefpodoxime—Diarrhoea—Carmustine—melanoma	0.00127	0.00134	CcSEcCtD
Cefpodoxime—Pruritus—Temozolomide—melanoma	0.00127	0.00133	CcSEcCtD
Cefpodoxime—Convulsion—Docetaxel—melanoma	0.00127	0.00133	CcSEcCtD
Cefpodoxime—Nausea—Bleomycin—melanoma	0.00126	0.00133	CcSEcCtD
Cefpodoxime—Hypertension—Docetaxel—melanoma	0.00126	0.00133	CcSEcCtD
Cefpodoxime—Vomiting—Dactinomycin—melanoma	0.00126	0.00133	CcSEcCtD
Cefpodoxime—Rash—Dactinomycin—melanoma	0.00125	0.00132	CcSEcCtD
Cefpodoxime—Myalgia—Docetaxel—melanoma	0.00125	0.00131	CcSEcCtD
Cefpodoxime—Chest pain—Docetaxel—melanoma	0.00125	0.00131	CcSEcCtD
Cefpodoxime—Dizziness—Carmustine—melanoma	0.00123	0.00129	CcSEcCtD
Cefpodoxime—Diarrhoea—Temozolomide—melanoma	0.00123	0.00129	CcSEcCtD
Cefpodoxime—Dry mouth—Docetaxel—melanoma	0.00122	0.00128	CcSEcCtD
Cefpodoxime—Confusional state—Docetaxel—melanoma	0.0012	0.00127	CcSEcCtD
Cefpodoxime—Anaphylactic shock—Docetaxel—melanoma	0.00119	0.00125	CcSEcCtD
Cefpodoxime—Dizziness—Temozolomide—melanoma	0.00119	0.00125	CcSEcCtD
Cefpodoxime—Vomiting—Carmustine—melanoma	0.00118	0.00124	CcSEcCtD
Cefpodoxime—Nausea—Dactinomycin—melanoma	0.00118	0.00124	CcSEcCtD
Cefpodoxime—Shock—Docetaxel—melanoma	0.00117	0.00123	CcSEcCtD
Cefpodoxime—Rash—Carmustine—melanoma	0.00117	0.00123	CcSEcCtD
Cefpodoxime—Dermatitis—Carmustine—melanoma	0.00117	0.00123	CcSEcCtD
Cefpodoxime—Thrombocytopenia—Docetaxel—melanoma	0.00117	0.00123	CcSEcCtD
Cefpodoxime—Headache—Carmustine—melanoma	0.00116	0.00122	CcSEcCtD
Cefpodoxime—Vomiting—Temozolomide—melanoma	0.00114	0.0012	CcSEcCtD
Cefpodoxime—Anorexia—Docetaxel—melanoma	0.00114	0.0012	CcSEcCtD
Cefpodoxime—Rash—Temozolomide—melanoma	0.00113	0.00119	CcSEcCtD
Cefpodoxime—Dermatitis—Temozolomide—melanoma	0.00113	0.00119	CcSEcCtD
Cefpodoxime—Headache—Temozolomide—melanoma	0.00112	0.00118	CcSEcCtD
Cefpodoxime—Hypotension—Docetaxel—melanoma	0.00112	0.00117	CcSEcCtD
Cefpodoxime—Nausea—Carmustine—melanoma	0.0011	0.00116	CcSEcCtD
Cefpodoxime—Musculoskeletal discomfort—Docetaxel—melanoma	0.00109	0.00114	CcSEcCtD
Cefpodoxime—Insomnia—Docetaxel—melanoma	0.00108	0.00113	CcSEcCtD
Cefpodoxime—Paraesthesia—Docetaxel—melanoma	0.00107	0.00113	CcSEcCtD
Cefpodoxime—Nausea—Temozolomide—melanoma	0.00107	0.00112	CcSEcCtD
Cefpodoxime—Dyspnoea—Docetaxel—melanoma	0.00106	0.00112	CcSEcCtD
Cefpodoxime—Somnolence—Docetaxel—melanoma	0.00106	0.00112	CcSEcCtD
Cefpodoxime—Dyspepsia—Docetaxel—melanoma	0.00105	0.0011	CcSEcCtD
Cefpodoxime—Decreased appetite—Docetaxel—melanoma	0.00104	0.00109	CcSEcCtD
Cefpodoxime—Gastrointestinal disorder—Docetaxel—melanoma	0.00103	0.00108	CcSEcCtD
Cefpodoxime—Fatigue—Docetaxel—melanoma	0.00103	0.00108	CcSEcCtD
Cefpodoxime—Constipation—Docetaxel—melanoma	0.00102	0.00107	CcSEcCtD
Cefpodoxime—Pain—Docetaxel—melanoma	0.00102	0.00107	CcSEcCtD
Cefpodoxime—Feeling abnormal—Docetaxel—melanoma	0.000984	0.00103	CcSEcCtD
Cefpodoxime—Gastrointestinal pain—Docetaxel—melanoma	0.000976	0.00103	CcSEcCtD
Cefpodoxime—Abdominal pain—Docetaxel—melanoma	0.000944	0.000992	CcSEcCtD
Cefpodoxime—Body temperature increased—Docetaxel—melanoma	0.000944	0.000992	CcSEcCtD
Cefpodoxime—Hypersensitivity—Docetaxel—melanoma	0.000879	0.000925	CcSEcCtD
Cefpodoxime—Asthenia—Docetaxel—melanoma	0.000856	0.0009	CcSEcCtD
Cefpodoxime—Pruritus—Docetaxel—melanoma	0.000845	0.000888	CcSEcCtD
Cefpodoxime—Diarrhoea—Docetaxel—melanoma	0.000817	0.000859	CcSEcCtD
Cefpodoxime—Dizziness—Docetaxel—melanoma	0.000789	0.00083	CcSEcCtD
Cefpodoxime—Vomiting—Docetaxel—melanoma	0.000759	0.000798	CcSEcCtD
Cefpodoxime—Rash—Docetaxel—melanoma	0.000753	0.000791	CcSEcCtD
Cefpodoxime—Dermatitis—Docetaxel—melanoma	0.000752	0.00079	CcSEcCtD
Cefpodoxime—Headache—Docetaxel—melanoma	0.000748	0.000786	CcSEcCtD
Cefpodoxime—Nausea—Docetaxel—melanoma	0.000709	0.000745	CcSEcCtD
Cefpodoxime—Cefazolin—ALB—melanoma	0.000622	0.0128	CrCbGaD
Cefpodoxime—Ceftriaxone—ALB—melanoma	0.00059	0.0121	CrCbGaD
Cefpodoxime—Cefalotin—ALB—melanoma	0.000517	0.0106	CrCbGaD
Cefpodoxime—Cephalexin—ALB—melanoma	0.00047	0.00964	CrCbGaD
